Country: Canada
Language: English
Source: Health Canada
AFOXOLANER; MILBEMYCIN OXIME
BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
150MG; 30MG
TABLET (CHEWABLE)
AFOXOLANER 150MG; MILBEMYCIN OXIME 30MG
ORAL
15G/50G
Prescription
DOGS
Active ingredient group (AIG) number: 0259990005
APPROVED
2018-03-01
NEXGARD SPECTRA ® BIAH: Version April 16, 2021 _PACKAGE INSERT _ VETERINARY USE ONLY PR NEXGARD SPECTRA ® Afoxolaner and Milbemycin Oxime Chewable Tablets DESCRIPTION: NEXGARD SPECTRA is a soft, beef-flavored chewable tablet. Each chewable tablet contains the active ingredients, afoxolaner (an ectoparasiticide of the isoxazoline family) and milbemycin oxime (an endoparasiticide belonging to the group of macrocyclic lactones). INDICATIONS: NEXGARD SPECTRA chewable tablets are indicated in dogs and puppies 8 weeks of age or older for: - the treatment and control of flea (_Ctenocephalides felis_) infestations, - the treatment and control of _ Dermacentor variabilis_ (American Dog Ticks), _ Ixodes _ _scapularis_ (Blacklegged Ticks), and _Amblyomma americanum_ (Lone Star Ticks), - the treatment of demodicosis caused by _Demodex canis_ - the prevention of heartworm disease (_Dirofilaria immitis_) (see CAUTIONS), - the treatment and control of intestinal nematode infections caused by adult hookworms (_Ancylostoma caninum_), adult roundworms (_Toxocara canis_ and _Toxascaris leonina_) and adult whipworms (_Trichuris vulpis_); - the reduction of _Borrelia burgdorferi _infections as a direct result of killing adult _Ixodes _ _scapularis _vector ticks. DOSAGE AND ADMINISTRATION: NEXGARD SPECTRA is given orally every 30 days, at the recommended dosage of 2.5 - 5 mg/kg of Afoxolaner and 0.5 - 1 mg/kg of Milbemycin Oxime. BODY WEIGHT (KG) AFOXOLANER PER CHEWABLE TABLET (MG) MILBEMYCIN OXIME PER CHEWABLE TABLET (MG) 2-3.7 9.4 1.9 3.8-7.5 18.8 3.8 7.6-15 37.5 7.5 15.1-30 75 15 30.1-60 150 30 NEXGARD SPECTRA can be administered with or without food. Care should be taken that the dog consumes the complete dose, and treated animals should be observed for a few minutes to ensure that part of the dose is not lost or rejected. If it is suspected that any of the dose has been lost, or vomiting occurs within 2 hours of administration, redose with another full dose. If a dose is missed, administer NEXGARD SPECTRA and resume an NEXGARD Read the complete document